Drug Type Bispecific antibody |
Synonyms- |
Target |
Mechanism FGFR1 stimulants(Fibroblast growth factor receptor 1 stimulants), KLB agonists(Klotho beta agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nonalcoholic Steatohepatitis | Phase 2 | - | - |